4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-25-022736
Chief Executive Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pilo Shlomo Chief Executive Officer | 2025-03-02 | Grant or award | +200,000 | $0.50 | $100,000 | 3,983,701 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pilo Shlomo Chief Executive Officer | 2025-03-02 | Grant or award · Warrant to purchase Common Stock | +100,000 | 1,100,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…